+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 425 Pages
  • November 2022
  • Region: Global
  • GlobalData
  • ID: 5706930
The publisher's Medical Devices sector report, “Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Bacteriology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bacteriology comprises of Reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bacteriology under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bacteriology and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bacteriology under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Bacteriology Overview
3 Products under Development
3.1 Bacteriology - Pipeline Products by Stage of Development
3.2 Bacteriology - Pipeline Products by Segment
3.3 Bacteriology - Pipeline Products by Territory
3.4 Bacteriology - Pipeline Products by Regulatory Path
3.5 Bacteriology - Pipeline Products by Estimated Approval Date
3.6 Bacteriology - Ongoing Clinical Trials
4 Bacteriology - Pipeline Products under Development by Companies
4.1 Bacteriology Companies - Pipeline Products by Stage of Development
4.2 Bacteriology - Pipeline Products by Stage of Development
5 Bacteriology Companies and Product Overview6 Bacteriology- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Bacteriology - Pipeline Products by Stage of Development
  • Bacteriology - Pipeline Products by Segment
  • Bacteriology - Pipeline Products by Territory
  • Bacteriology - Pipeline Products by Regulatory Path
  • Bacteriology - Pipeline Products by Estimated Approval Date
  • Bacteriology - Ongoing Clinical Trials
  • Bacteriology Companies - Pipeline Products by Stage of Development
  • Bacteriology - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Bacteriology - Pipeline Products by Stage of Development
  • Bacteriology - Pipeline Products by Segment
  • Bacteriology - Pipeline Products by Territory
  • Bacteriology - Pipeline Products by Regulatory Path
  • Bacteriology - Pipeline Products by Estimated Approval Date
  • Bacteriology - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3a-Diagnostics GmbH
  • Abacus Diagnostica Ltd
  • Adaltis Srl
  • Advanced Laboratory Services, INC.
  • Akonni Biosystems Inc
  • Alere Inc
  • American Bio Medica Corp
  • Amity University
  • Angle Biosciences Inc
  • Antigen Discovery Inc
  • Applied BioCode Inc
  • Ares Genetics GmbH
  • Aseptika Ltd
  • Astute Medical Inc
  • Asylia Diagnostics BV
  • Ayanda Biosystems SA (Inactive)
  • Beckman Coulter Inc
  • Biocartis Group NV
  • Biocrates Life Sciences AG
  • BioFilm Control SAS
  • BioHelix Corp
  • Biointerfaces Institute
  • Biois Corp
  • BioMaxima SA
  • bioMerieux SA
  • Biopeptide corp
  • BioSentinel Pharmaceuticals, Inc.
  • Biotechnology Assets SA
  • Bordeaux University Hospital
  • Brigham Young University Inc
  • C3J Therapeutics Inc (Inactive)
  • Calypte Biomedical Corporation
  • Carolina Liquid Chemistries Corp
  • CellCarta Biosciences Inc
  • Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
  • Cepheid Inc
  • Children's Hospital of Michigan
  • China Medical Technologies Inc (Inactive)
  • Co-Diagnostics Inc
  • Conrad
  • Coris BioConcept
  • Courtagen Life Sciences Inc
  • Cubed Laboratories LLC
  • Cupid Ltd
  • Daan Gene Co Ltd
  • Defence Science and Technology Laboratory
  • DIANA Biotechnologies SRO
  • DiaSorin SpA
  • DSX Therapeutics LLC
  • Ellume Ltd
  • Emory University
  • Enigma Diagnostics Ltd (Inactive)
  • EUROIMMUN US LLC
  • First Light Diagnostics Inc
  • FK-Biotecnologia SA
  • Focus Diagnostics Inc
  • Foundation for Innovative New Diagnostics
  • Fyodor Biotechnologies, Inc.
  • Genekam Biotechnology AG
  • Genome Diagnostics Pvt Ltd
  • GNA Biosolutions GmbH
  • Godx Inc
  • Great Basin Scientific Inc.
  • Guanine Inc
  • HAV Vaccines Ltd
  • HDT Biotech Corp
  • Health and Bliss (Inactive)
  • Helixbind Inc
  • Helmholtz Centre for Infection Research
  • HiberGene Diagnostics Ltd
  • Hutman Diagnostics AG
  • iCubate Inc
  • InBios International Inc
  • Innovative Biosensors, Inc.
  • InstantLabs Inc
  • Institute for Development Research
  • Jagiellonian University
  • Johns Hopkins University
  • Kaneka Corp
  • L2 Diagnostics LLC
  • Luminex Corp
  • Marx Biotechnology Ltd
  • Master Diagnostica Sociedad Limitada
  • Medica Corp
  • Meridian Bioscience Inc
  • MicroPhage Inc (Inactive)
  • Molecular Detection Inc (Inactive)
  • MyCartis NV
  • Mylab Discovery Solutions Pvt Ltd
  • Nanosphere Inc (Inactive)
  • National Cheng-Kung University Hospital
  • Naval Medical Research Center
  • NeuMoDx Molecular Inc
  • Newcastle University
  • North Carolina State University
  • Novartis AG
  • OpGen Inc
  • Optolane Technologies Inc
  • Pathogenica Inc
  • Pennsylvania State University
  • Pictor Ltd
  • PositiveID Corp
  • Presymptom Health Ltd
  • Proactive Oral Solutions, Inc.
  • ProCelo AS
  • Promyco Diagnostics Ltd (Inactive)
  • Qiagen NV
  • Quidel Corp
  • RedHill Biopharma Ltd
  • Renishaw Plc
  • Rheonix Inc
  • Roche Diagnostics International Ltd
  • Rockefeller University
  • Sansure Biotech Inc
  • Seegene Inc
  • Sex Positive Diagnostics
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Shenzhen New Industries Biomedical Engineering Co Ltd
  • SomaLogic Inc
  • Spanish National Research Council
  • SpeeDx Pty Ltd
  • TBG Diagnostics Ltd
  • The University of Nottingham
  • Tosoh Bioscience Inc
  • Transfusion & Transplantation Technologies (Inactive)
  • Trillium Diagnostics LLC (Inactive)
  • University at Buffalo
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Cincinnati
  • University of Leicester
  • University of Liverpool
  • University of Maryland Baltimore
  • University of Melbourne
  • University of Michigan
  • University of Oxford
  • University of Pennsylvania
  • University of Strathclyde
  • University of Washington
  • University of Wisconsin Madison
  • Verax Biomedical Inc
  • Victory Square Health Inc
  • Yale University